Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of MenACWY versus Menjugate in healthy toddlers
2007-004754-82Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Meningococcal ACWY conjugate vaccine in meningococcal disease (2 arms), sponsored by Novartis. Primary endpoints: Serogroup C hSBA response non-inferiority, Serogroup C hSBA geometric mean titers and 2 more. Started Oct 2007; status: completed.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2007-004754-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004754-82.